Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Anti-Cancer Agents in Medicinal Chemistry

• Publication date

  2016-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1871520615666150803124139PMID 26234362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma.

  2015cited by this paper
• Class I-specific histone deacetylase inhibitor MS-275 overrides TRAIL-resistance in melanoma cells by downregulating c-FLIP.

  2014cited by this paper
• Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma

  2014cited by this paper
• Kaempferol Targets RSK2 and MSK1 to Suppress UV Radiation-Induced Skin Cancer

  2014cited by this paper
• POT1 loss-of-function variants predispose to familial melanoma

  2014cited by this paper
• Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)

  2014cited by this paper
• Deletion of the MGMT gene in familial melanoma

  2014cited by this paper
• Predictors of BRAF Mutation in Melanocytic Nevi: Analysis Across Regions With Different UV Radiation Exposure

  2013cited by this paper
• Class II‐specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL‐8 expression in human melanoma cells

  2013cited by this paper
• Impaired PIASy-Tip60 signaling weakens activation of p53 in melanoma.

  2013cited by this paper
• PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma

  2013cited by this paper
• Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma.

  2013cited by this paper
• Metastatic mucosal melanoma: imaging patterns of metastasis and recurrence

  2013cited by this paper
• Primary mucosal melanomas: a comprehensive review.

  2012cited by this paper
• Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis.

  2012cited by this paper
• miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.

  2012cited by this paper
• Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family.

  2012cited by this paper
• Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families

  2012cited by this paper
• Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma

  2012cited by this paper
• A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth

  2012cited by this paper
• Epigenetic targets of some toxicologically relevant metals: a review of the literature

  2012cited by this paper
• microRNA‐21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells

  2012cited by this paper
• H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma

  2012cited by this paper
• Sorafenib in melanoma

  2012cited by this paper
• Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations.

  2012cited by this paper
• Epigenetic regulation of microRNA‐375 and its role in melanoma development in humans

  2011cited by this paper
• Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma

  2011cited by this paper
• Epigenetic Regulation of MicroRNA Genes and the Role of miR-34b in Cell Invasion and Motility in Human Melanoma

  2011cited by this paper
• Germline mutations in BAP1 predispose to melanocytic tumors

  2011cited by this paper
• Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma

  2011cited by this paper
• The RAG1 V(D)J recombinase/ubiquitin ligase promotes ubiquitylation of acetylated, phosphorylated histone 3.3.

  2011cited by this paper
• The SETDB1 histone methyltransferase is recurrently amplified in and accelerates melanoma

  2011cited by this paper
• Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma

  2011cited by this paper
• miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions

  2011cited by this paper
• Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.

  2011cited by this paper
• c-Kit mutants require hypoxia-inducible factor 1α to transform melanocytes

  2010cited by this paper
• TSLC1 gene silencing in cutaneous melanoma

  2010cited by this paper
• Identification and analysis of an early diagnostic marker for malignant melanoma: ZAR1 intra-genic differential methylation.

  2010cited by this paper
• The impact of histone post-translational modifications on developmental gene regulation

  2010cited by this paper
• Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma

  2010cited by this paper
• The clinical development of histone deacetylase inhibitors as targeted anticancer drugs

  2010cited by this paper
• Genetics of Uveal Melanoma and Cutaneous Melanoma: Two of a Kind?

  2010cited by this paper
• Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies

  2010cited by this paper
• Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns

  2010cited by this paper
• Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT

  2010cited by this paper
• Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

  2010cited by this paper
• Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma

  2009cited by this paper
• Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor

  2009cited by this paper
• Epigenetics in human melanoma.

  2009cited by this paper
• Epigenetic marks in melanoma

  2009cited by this paper
• Molecular Markers of Tumor Progression in Melanoma

  2009cited by this paper
• Applications of genomics in melanoma oncogene discovery.

  2009cited by this paper
• BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-κB binding site of the uPA promoter

  2009cited by this paper
• Molecular prognostic testing and individualized patient care in uveal melanoma.

  2009cited by this paper
• Positive interaction between light iris color and ultraviolet radiation in relation to the risk of uveal melanoma: a case-control study.

  2009cited by this paper
• A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma

  2009cited by this paper
• CpG Island Methylator Phenotype Predicts Progression of Malignant Melanoma

  2009cited by this paper
• Cancer/testis (CT) antigens: Potential targets for immunotherapy

  2009cited by this paper
• Genetic risk factors for melanoma

  2009cited by this paper
• Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk.

  2009cited by this paper
• Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.

  2009cited by this paper
• Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker

  2009cited by this paper
• Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial

  2009cited by this paper
• Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site

  2008cited by this paper
• Role of ING4 in human melanoma cell migration, invasion and patient survival.

  2008cited by this paper
• Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.

  2008cited by this paper
• The Protective Role of Melanin Against UV Damage in Human Skin †

  2008cited by this paper
• Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

  2008cited by this paper
• Integrin β3 expression is regulated by let-7a miRNA in malignant melanoma

  2008cited by this paper
• Epigenetics in cancer.

  2008cited by this paper
• BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.

  2008cited by this paper
• Histone deacetylase inhibitors: mechanisms and clinical significance in cancer: HDAC inhibitor-induced apoptosis.

  2008cited by this paper
• The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.

  2008cited by this paper
• Modeling genomic diversity and tumor dependency in malignant melanoma.

  2008cited by this paper
• The genetics of malignant melanoma.

  2008cited by this paper
• Molecular Pathways Mediating Liver Metastasis in Patients with Uveal Melanoma

  2008cited by this paper
• MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth

  2008cited by this paper
• Cutaneous melanoma: fishing with chips.

  2008cited by this paper
• Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling

  2008cited by this paper
• Expression of polycomb group protein EZH2 in nevi and melanoma

  2007cited by this paper
• Functional Up-regulation of Human Leukocyte Antigen Class I Antigens Expression by 5-aza-2′-deoxycytidine in Cutaneous Melanoma: Immunotherapeutic Implications

  2007cited by this paper
• Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi

  2007cited by this paper
• How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers

  2007cited by this paper
• DNA mismatch repair protein expression and microsatellite instability in primary mucosal melanomas of the head and neck

  2007cited by this paper
• Toward a molecular classification of melanoma.

  2007cited by this paper
• Comprehensive Expression Profiling of Tumor Cell Lines Identifies Molecular Signatures of Melanoma Progression

  2007cited by this paper
• Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.

  2007cited by this paper
• Loss of oncostatin M receptor beta in metastatic melanoma cells.

  2007cited by this paper
• Chromatin modifications and their function.

  2007cited by this paper
• Epigenetic events in malignant melanoma.

  2007cited by this paper
• Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors.

  2007cited by this paper
• Prognostic Significance of Nuclear ING3 Expression in Human Cutaneous Melanoma

  2007cited by this paper
• DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma.

  2007cited by this paper
• Valproic acid induces apoptosis, p16INK4A upregulation and sensitization to chemotherapy in human melanoma cells

  2007cited by this paper
• A single cycle of treatment with temozolomide, alone or combined with O(6)-benzylguanine, induces strong chemoresistance in melanoma cell clones in vitro: role of O(6)-methylguanine-DNA methyltransferase and the mismatch repair system.

  2006cited by this paper
• MicroRNA-cancer connection: the beginning of a new tale.

  2006cited by this paper
• Genetic Alterations in Signaling Pathways in Melanoma

  2006cited by this paper
• The genetics of melanoma.

  2006cited by this paper
• Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.

  2006cited by this paper
• Phase I Study of Decitabine-Mediated Gene Expression in Patients with Cancers Involving the Lungs, Esophagus, or Pleura

  2006cited by this paper

• Identification of Molecular Characteristics and New Prognostic Targets for Thymoma by Multiomics Analysis

  2021cites this paper
• Targeting Epigenetic Modifications in UM

  2020cites this paper
• Targeting Epigenetic Modifications in Uveal Melanoma

  2020influential citation
• Genome-wide DNA methylation profile of thymomas and potential epigenetic regulation of thymoma subtypes

  2019cites this paper
• DNA Methylation and Uveal Melanoma

  2018cites this paper
• Genistein reduces proliferation of EP3‐expressing melanoma cells through inhibition of PGE2‐induced IL‐8 expression

  2018cites this paper
• Role of Epigenetics in Uveal Melanoma

  2017influential citation
• Clinical Ophthalmology Dovepress

  year unknowncites this paper